Brookdale Senior Living Inc. (BKD) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Mar 2024.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Mar 2024

Mar 6, 2024

Get an email when BKD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 19, 2025	Lee S Wielansky Director	Sold10b5-1 plan	10,000	$6.82	$68k	4.3%	Form 4
Mar 7, 2025	Lee S Wielansky Director	Sold10b5-1 plan	10,000	$5.84	$58k	4.1%	Form 4
Dec 5, 2024	Lee S Wielansky Director	SoldNo plan	10,000	$5.62	$56k	4.5%	Form 4

May 19, 202510b5-1 plan
Lee S Wielansky
Director · sold 10,000 at $6.82
$68k
4.3% of stake
Mar 7, 202510b5-1 plan
Lee S Wielansky
Director · sold 10,000 at $5.84
$58k
4.1% of stake
Dec 5, 2024No plan
Lee S Wielansky
Director · sold 10,000 at $5.62
$56k
4.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BKD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Nursing & Personal Care Facilities

HCSGHealthcare Services Group Inc.

SNDASonida Senior Living Inc.

NHCNational HealthCare Corporation

ENSGThe Ensign Group, Inc.

PACSPacs Group Inc.

EXASExact Sciences Corp

SGRYSurgery Partners Inc.

AHCOAdaptHealth Corp.

Spot a number that looks wrong? Check it in BKD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BKD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.